2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide

C229H244FN41O42S — CID 161002949

IUPAC2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide
SMILESCC1=NCC(=O)N(CC(=O)N[C@H](C(=O)c2nnc(Cc3cccc(C)c3)o2)C(C)C)c2cc(-c3ccccc3)sc21.COC(=O)CC[C@H]1NC(=O)N(CC(=O)N[C@H](C(=O)c2nnc(Cc3cccc(C)c3)o2)C(C)C)C1=O.COc1ccccc1C1=NCC(=O)N(CC(=O)N[C@H](C(=O)c2nnc(Cc3cccc(C)c3)o2)C(C)C)c2ccccc21.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)CN=C(c4ccc5c(c4)OCO5)c4ccccc43)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)NC(c4ccccc4)(c4ccccc4)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)N[C@H](CC(=O)N(C)C)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)N[C@H](CC(C)C)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)Cn3c(-c4ccc(F)cc4)ccc(N)c3=O)C(C)C)o2)c1
InChIInChI=1S/C33H31N5O6.C33H33N5O5.C32H31N5O5.C31H31N5O4S.C28H28FN5O4.C24H30N6O6.C24H29N5O7.C24H31N5O5/c1-19(2)30(32(41)33-37-36-28(44-33)14-21-8-6-7-20(3)13-21)35-27(39)17-38-24-10-5-4-9-23(24)31(34-16-29(38)40)22-11-12-25-26(15-22)43-18-42-25;1-20(2)30(32(41)33-37-36-28(43-33)17-22-11-9-10-21(3)16-22)35-27(39)19-38-25-14-7-5-12-23(25)31(34-18-29(38)40)24-13-6-8-15-26(24)42-4;1-20(2)27(28(39)29-36-35-26(42-29)18-22-12-10-11-21(3)17-22)33-25(38)19-37-30(40)32(34-31(37)41,23-13-6-4-7-14-23)24-15-8-5-9-16-24;1-18(2)28(29(39)31-35-34-26(40-31)14-21-10-8-9-19(3)13-21)33-25(37)17-36-23-15-24(22-11-6-5-7-12-22)41-30(23)20(4)32-16-27(36)38;1-16(2)25(26(36)27-33-32-24(38-27)14-18-6-4-5-17(3)13-18)31-23(35)15-34-22(12-11-21(30)28(34)37)19-7-9-20(29)10-8-19;1-13(2)20(21(33)22-28-27-18(36-22)10-15-8-6-7-14(3)9-15)26-17(31)12-30-23(34)16(25-24(30)35)11-19(32)29(4)5;1-13(2)20(21(32)22-28-27-18(36-22)11-15-7-5-6-14(3)10-15)26-17(30)12-29-23(33)16(25-24(29)34)8-9-19(31)35-4;1-13(2)9-17-23(32)29(24(33)25-17)12-18(30)26-20(14(3)4)21(31)22-28-27-19(34-22)11-16-8-6-7-15(5)10-16/h4-13,15,19,30H,14,16-18H2,1-3H3,(H,35,39);5-16,20,30H,17-19H2,1-4H3,(H,35,39);4-17,20,27H,18-19H2,1-3H3,(H,33,38)(H,34,41);5-13,15,18,28H,14,16-17H2,1-4H3,(H,33,37);4-13,16,25H,14-15,30H2,1-3H3,(H,31,35);6-9,13,16,20H,10-12H2,1-5H3,(H,25,35)(H,26,31);5-7,10,13,16,20H,8-9,11-12H2,1-4H3,(H,25,34)(H,26,30);6-8,10,13-14,17,20H,9,11-12H2,1-5H3,(H,25,33)(H,26,30)/t2*30-;27-;28-;25-;2*16-,20+;17-,20+/m00000111/s1
InChIKeyTWCWDVCXNAAOEW-OTOWBIAXSA-N
MW4293.78 g/mol
LogP24.41
Rot. Bonds78

About 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide

2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide (PubChem CID 161002949) has the molecular formula C229H244FN41O42S and a molecular weight of 4293.78 g/mol. Its IUPAC name is 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide.

Molecular Properties

Compound Name2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide
PubChem CID161002949
Molecular FormulaC229H244FN41O42S
Molecular Weight4293.78 g/mol
Exact Mass4290.79
IUPAC Name2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide
SMILESCC1=NCC(=O)N(CC(=O)N[C@H](C(=O)c2nnc(Cc3cccc(C)c3)o2)C(C)C)c2cc(-c3ccccc3)sc21.COC(=O)CC[C@H]1NC(=O)N(CC(=O)N[C@H](C(=O)c2nnc(Cc3cccc(C)c3)o2)C(C)C)C1=O.COc1ccccc1C1=NCC(=O)N(CC(=O)N[C@H](C(=O)c2nnc(Cc3cccc(C)c3)o2)C(C)C)c2ccccc21.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)CN=C(c4ccc5c(c4)OCO5)c4ccccc43)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)NC(c4ccccc4)(c4ccccc4)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)N[C@H](CC(=O)N(C)C)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)N[C@H](CC(C)C)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)Cn3c(-c4ccc(F)cc4)ccc(N)c3=O)C(C)C)o2)c1
InChIInChI=1S/C33H31N5O6.C33H33N5O5.C32H31N5O5.C31H31N5O4S.C28H28FN5O4.C24H30N6O6.C24H29N5O7.C24H31N5O5/c1-19(2)30(32(41)33-37-36-28(44-33)14-21-8-6-7-20(3)13-21)35-27(39)17-38-24-10-5-4-9-23(24)31(34-16-29(38)40)22-11-12-25-26(15-22)43-18-42-25;1-20(2)30(32(41)33-37-36-28(43-33)17-22-11-9-10-21(3)16-22)35-27(39)19-38-25-14-7-5-12-23(25)31(34-18-29(38)40)24-13-6-8-15-26(24)42-4;1-20(2)27(28(39)29-36-35-26(42-29)18-22-12-10-11-21(3)17-22)33-25(38)19-37-30(40)32(34-31(37)41,23-13-6-4-7-14-23)24-15-8-5-9-16-24;1-18(2)28(29(39)31-35-34-26(40-31)14-21-10-8-9-19(3)13-21)33-25(37)17-36-23-15-24(22-11-6-5-7-12-22)41-30(23)20(4)32-16-27(36)38;1-16(2)25(26(36)27-33-32-24(38-27)14-18-6-4-5-17(3)13-18)31-23(35)15-34-22(12-11-21(30)28(34)37)19-7-9-20(29)10-8-19;1-13(2)20(21(33)22-28-27-18(36-22)10-15-8-6-7-14(3)9-15)26-17(31)12-30-23(34)16(25-24(30)35)11-19(32)29(4)5;1-13(2)20(21(32)22-28-27-18(36-22)11-15-7-5-6-14(3)10-15)26-17(30)12-29-23(33)16(25-24(29)34)8-9-19(31)35-4;1-13(2)9-17-23(32)29(24(33)25-17)12-18(30)26-20(14(3)4)21(31)22-28-27-19(34-22)11-16-8-6-7-15(5)10-16/h4-13,15,19,30H,14,16-18H2,1-3H3,(H,35,39);5-16,20,30H,17-19H2,1-4H3,(H,35,39);4-17,20,27H,18-19H2,1-3H3,(H,33,38)(H,34,41);5-13,15,18,28H,14,16-17H2,1-4H3,(H,33,37);4-13,16,25H,14-15,30H2,1-3H3,(H,31,35);6-9,13,16,20H,10-12H2,1-5H3,(H,25,35)(H,26,31);5-7,10,13,16,20H,8-9,11-12H2,1-4H3,(H,25,34)(H,26,30);6-8,10,13-14,17,20H,9,11-12H2,1-5H3,(H,25,33)(H,26,30)/t2*30-;27-;28-;25-;2*16-,20+;17-,20+/m00000111/s1
InChIKeyTWCWDVCXNAAOEW-OTOWBIAXSA-N
XLogP24.41
TPSA1098.69 Ų
H-Bond Donors13
H-Bond Acceptors64
Rotatable Bonds78
Heavy Atoms314
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5004293.78
LogP ≤ 524.41
H-Bond Donors ≤ 513
H-Bond Acceptors ≤ 1064

Analyze 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide?
The IUPAC name of 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide (CID 161002949) is 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide.
What is the SMILES notation for 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide?
The canonical SMILES for 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide is CC1=NCC(=O)N(CC(=O)N[C@H](C(=O)c2nnc(Cc3cccc(C)c3)o2)C(C)C)c2cc(-c3ccccc3)sc21.COC(=O)CC[C@H]1NC(=O)N(CC(=O)N[C@H](C(=O)c2nnc(Cc3cccc(C)c3)o2)C(C)C)C1=O.COc1ccccc1C1=NCC(=O)N(CC(=O)N[C@H](C(=O)c2nnc(Cc3cccc(C)c3)o2)C(C)C)c2ccccc21.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)CN=C(c4ccc5c(c4)OCO5)c4ccccc43)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)NC(c4ccccc4)(c4ccccc4)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)N[C@H](CC(=O)N(C)C)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)CN3C(=O)N[C@H](CC(C)C)C3=O)C(C)C)o2)c1.Cc1cccc(Cc2nnc(C(=O)[C@@H](NC(=O)Cn3c(-c4ccc(F)cc4)ccc(N)c3=O)C(C)C)o2)c1.
What is the InChIKey of 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide?
The InChIKey is TWCWDVCXNAAOEW-OTOWBIAXSA-N. The full InChI is InChI=1S/C33H31N5O6.C33H33N5O5.C32H31N5O5.C31H31N5O4S.C28H28FN5O4.C24H30N6O6.C24H29N5O7.C24H31N5O5/c1-19(2)30(32(41)33-37-36-28(44-33)14-21-8-6-7-20(3)13-21)35-27(39)17-38-24-10-5-4-9-23(24)31(34-16-29(38)40)22-11-12-25-26(15-22)43-18-42-25;1-20(2)30(32(41)33-37-36-28(43-33)17-22-11-9-10-21(3)16-22)35-27(39)19-38-25-14-7-5-12-23(25)31(34-18-29(38)40)24-13-6-8-15-26(24)42-4;1-20(2)27(28(39)29-36-35-26(42-29)18-22-12-10-11-21(3)17-22)33-25(38)19-37-30(40)32(34-31(37)41,23-13-6-4-7-14-23)24-15-8-5-9-16-24;1-18(2)28(29(39)31-35-34-26(40-31)14-21-10-8-9-19(3)13-21)33-25(37)17-36-23-15-24(22-11-6-5-7-12-22)41-30(23)20(4)32-16-27(36)38;1-16(2)25(26(36)27-33-32-24(38-27)14-18-6-4-5-17(3)13-18)31-23(35)15-34-22(12-11-21(30)28(34)37)19-7-9-20(29)10-8-19;1-13(2)20(21(33)22-28-27-18(36-22)10-15-8-6-7-14(3)9-15)26-17(31)12-30-23(34)16(25-24(30)35)11-19(32)29(4)5;1-13(2)20(21(32)22-28-27-18(36-22)11-15-7-5-6-14(3)10-15)26-17(30)12-29-23(33)16(25-24(29)34)8-9-19(31)35-4;1-13(2)9-17-23(32)29(24(33)25-17)12-18(30)26-20(14(3)4)21(31)22-28-27-19(34-22)11-16-8-6-7-15(5)10-16/h4-13,15,19,30H,14,16-18H2,1-3H3,(H,35,39);5-16,20,30H,17-19H2,1-4H3,(H,35,39);4-17,20,27H,18-19H2,1-3H3,(H,33,38)(H,34,41);5-13,15,18,28H,14,16-17H2,1-4H3,(H,33,37);4-13,16,25H,14-15,30H2,1-3H3,(H,31,35);6-9,13,16,20H,10-12H2,1-5H3,(H,25,35)(H,26,31);5-7,10,13,16,20H,8-9,11-12H2,1-4H3,(H,25,34)(H,26,30);6-8,10,13-14,17,20H,9,11-12H2,1-5H3,(H,25,33)(H,26,30)/t2*30-;27-;28-;25-;2*16-,20+;17-,20+/m00000111/s1.
What are the key properties of 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide?
2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide has a molecular weight of 4293.78 g/mol, XLogP of 24.41, 78 rotatable bonds, 13 hydrogen bond donors, and 64 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-amino-6-(4-fluorophenyl)-2-oxo-1-pyridinyl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(1,3-benzodioxol-5-yl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;N,N-dimethyl-2-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]acetamide;2-(2,5-dioxo-4,4-diphenylimidazolidin-1-yl)-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;2-[5-(2-methoxyphenyl)-2-oxo-3H-1,4-benzodiazepin-1-yl]-N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]acetamide;methyl 3-[(4R)-1-[2-[[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]amino]-2-oxoethyl]-2,5-dioxoimidazolidin-4-yl]propanoate;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-(5-methyl-2-oxo-7-phenyl-3H-thieno[3,2-e][1,4]diazepin-1-yl)acetamide;N-[(2S)-3-methyl-1-[5-[(3-methylphenyl)methyl]-1,3,4-oxadiazol-2-yl]-1-oxobutan-2-yl]-2-[(4R)-4-(2-methylpropyl)-2,5-dioxoimidazolidin-1-yl]acetamide is sourced from PubChem (CID 161002949), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).